Clinical Research Directory
Browse clinical research sites, groups, and studies.
Bevacizumab Versus Triamcinolone Acetonide for the Treatment of Keloids.
Sponsor: Kasr El Aini Hospital
Summary
The study compares the efficacy and safety of intralesional bevacizumab versus corticosteroids for the treatment of keloids. Assessment will be done clinically by the use of Modified Vancouver Scar Scale. Erythema index will be measured by spectrophotometry. The levels of Vascular Endothelial Growth Factor, collagen type 1 and collagen type 3 in the lesions before and after each treatment modality.
Official title: Efficacy of Intralesional Bevacizumab Versus Intralesional Triamcinolone Acetonide Injection in the Treatment of Keloids.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
28
Start Date
2023-09-01
Completion Date
2025-07-01
Last Updated
2025-06-10
Healthy Volunteers
No
Conditions
Interventions
Bevacizumab
anti-VEGF
Triamcinolone Acetonide
corticosteroid
Locations (1)
Kasr El Ainy University Hospital, faculty of medicine, Cairo university
Cairo, El Manial, Egypt